RxDoctor Payments DataLook up a doctor →

Monica Bertagnolli

Surgery · Boston, MANPI 1528024270

Payments from drug & device makers

$155,258,300in general payments, 2019–2025

Across 2,120 payments — averaging $73,235 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$97.5M
  • Seagen Inc.$26.7M
  • Janssen Research & Development, LLC$16.1M
  • AstraZeneca$9M
  • Genentech, Inc.$2.7M
  • Takeda Pharmaceuticals U.S.A., Inc.$1.9M
  • plus $1.3M from 6 others
$171,998in research payments, 2019–2025

Across 3 payments — averaging $57,333 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Lilly USA, LLC$172K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer150$97,533,850
Seagen Inc.141$26,661,858
Janssen Research & Development, LLC236$16,128,493
AstraZeneca12$8,982,943
Genentech, Inc.11$2,707,089
Takeda Pharmaceuticals U.S.A., Inc.21$1,915,628
Exelixis Inc.1,537$880,235
Bristol Myers Squibb3$264,445
Servier Affaires Medicales2$91,773
Novartis5$58,975
Bayer1$29,341
GSK1$3,670

How this compares

$155,258,300 in reported general payments places this provider in the 95th percentile of 694 surgery providers in Massachusetts.

See all surgery providers in Massachusetts

Other surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →